Correction

This article refers to:

Treatment response and neurofilament light chain levels with long-term patisiran in hereditary transthyretin-mediated amyloidosis with polyneuropathy: 24-month results of an open-label extension study

Article title: Treatment response and neurofilament light chain levels with long-term patisiran in hereditary transthyretin-mediated amyloidosis with polyneuropathy:24-month results of an open-label extension study

Authors: Ticau S, Aldinc E, Polydefkis M, Adams D, Coelho T, Ueda M, Hale C, Vest J, Nioi P and the Patisiran Global OLE Collaborators

Journal: Amyloid

DOI: https://doi.org/10.1080/13506129.2023.2232520

The above article has been published with minor errors in Figures 2B and 3B.

The changes needed are:

 • On the x axes of both figures, ‘30 months/OLE 12 months’ should be ’36 months/OLE 12 months’,

 • And, on the x axes of both figures, ‘42 months/OLE 24 months’ should be ’48 months/OLE 24 months’.

This has now been corrected in both the online and print versions.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.